Innovation in bone healing and tissue repair

The charts below summarize the clinical and regulatory development status of Kuros Biosciences’ lead product candidates.

Sealants (CE Mark/PMA)

 

Synthetic Orthobiologics (CE Mark/510k)

 

Fibrin/PTH Orthobilogics (NDA/MAA)

Kuros Biosciences AG
Wagistrasse 25, 8952 Schlieren, Switzerland
Tel: +41 (0)44 200 56 00   Fax: +41 (0)44 200 56 01   Email: info@kuros.ch

About Kuros

  1. Overview
  2. Management
  3. Board

Products

  1. Pipeline
  2. Orthobiologics
    Fracture repair
    KUR-111
    KUR-113
    Spinal fusion
    KUR-113
    Solitary Bone Cysts
    KUR-112
  3. Sealants
    Neuroseal (KUR-023)

Technologies

  1. Overview
  2. Fibrin-based
  3. Synthetic-based
  4. Immune modulation
  5. Publications

Partnerships

  1. Collaborations
  2. Business development

Investors

  1. Share price
  2. Regulatory filings
  3. Reports & presentations
  4. Calendar
  5. Corporate governance
  6. Stay informed

News

  1. Press releases
  2. Conferences & Events

Contact

  1. Location
Pipeline

The charts below summarize the clinical and regulatory development status of Kuros Biosciences’ lead product candidates.

Sealants (CE Mark/PMA)

 

Synthetic Orthobiologics (CE Mark/510k)

 

Fibrin/PTH Orthobilogics (NDA/MAA)